期刊文献+

热熔分散法制备依巴斯汀分散片 被引量:2

Preparation of ebastine dispersible tablets by hot-melt dispersion
下载PDF
导出
摘要 目的以羟丙甲纤维素为载体,用热熔分散法制备依巴斯汀分散片。方法将依巴斯汀原料熔融分散于羟丙甲纤维素热水溶液中,以甘露醇吸附药液,制备分散片。用差示扫描量热分析和X-射线粉末衍射分析热熔分散体特征,并比较自制分散片和原研药的溶出曲线。结果 X-射线衍射和差示扫描量热分析表明,热熔分散体中的依巴斯汀仍具有原料晶型的主要特征,体外溶出结果显示,依巴斯汀热熔分散体的15min溶出度可达到95.07%,显著高于微粉化的依巴斯汀原料药,分散片30min的累积溶出度也比原研药高出约30%。结论以羟丙甲纤维素为载体的热熔分散技术,可显著提高依巴斯汀的溶出度。 Objective To prepare ebastine dispersible tablets by hot-melt dispersion method using hypromellose as a carrier.Methods Ebastine was heated to melt and dispersed in hot solution of hypromellose.The mixture was adsorbed by mannitol and then used to prepare dispersible tablets.The characteristics of hot-melt dispersion were analyzed by the methods of differential scanning calorimetry and X-ray powder diffraction.A comparison of dissolution curves between self-made dispersible tablets and original ebastine tablets was performed.Results The analysis of X-ray diffraction and differential scanning calorimetry showed that the ebastine in solid matrix remained the main crystalline characteristics.The dissolution of ebastine hot-melt dispersion was 95.07% in 15 min in vitro, which was significantly higher than that of micronized ebastine raw material.Moreover, the accumulative dissolution of ebastine dispersible tablets in 30 min was about 30% higher than the original drug.Conclusion The method of hot-melt dispersion using hypromellose as a carrier improved the ebastine dissolution significantly.
出处 《药学实践杂志》 CAS 2017年第5期415-418,471,共5页 Journal of Pharmaceutical Practice
关键词 依巴斯汀 溶出度 羟丙甲纤维素 ebastine dissolution hypromellose
  • 相关文献

参考文献1

二级参考文献8

  • 1Anant Paradkar,Anshuman A. Ambike,Bhimrao K. Jadhav,K.R. Mahadik.Characterization of curcumin–PVP solid dispersion obtained by spray drying[J].International Journal of Pharmaceutics.2003(1)
  • 2Mayumi Asada,Hirokazu Takahashi,Hirokazu Okamoto,Hideo Tanino,Kazumi Danjo.Theophylline particle design using chitosan by the spray drying[J].International Journal of Pharmaceutics.2003(1)
  • 3Duncan Q.M Craig.The mechanisms of drug release from solid dispersions in water-soluble polymers[J].International Journal of Pharmaceutics.2002(2)
  • 4Geert Verreck,Karel Six,Guy Van den Mooter,Lieven Baert,Jef Peeters,Marcus E. Brewster.Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion—part I[J].International Journal of Pharmaceutics.2002(1)
  • 5Shui-Mei Khoo,Christopher J.H. Porter,William N. Charman.The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment[J].International Journal of Pharmaceutics.2000(1)
  • 6F. Usui,K. Maeda,A. Kusai,M. Ikeda,K. Nishimura,K. Yamamoto.Dissolution improvement of RS-8359 by the solid dispersion prepared by the solvent method[J].International Journal of Pharmaceutics.1998(2)
  • 7Tetsuya Ozeki,Hiroshi Yuasa,Yoshio Kanaya.Application of the solid dispersion method to the controlled release of medicine. IX. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxypropylcellulose and the interaction between medicine and polymers[J].International Journal of Pharmaceutics.1997(2)
  • 8Wiseman L R,Faulds D.Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders[].Drugs.1994

共引文献1

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部